Aug. 30 Financial Quick Takes: Remiges launches second fund with $30M from Taiho; ERADA gets grant for malaria diagnostic

Taiho to invest $30M in Remiges' second venture fund
Remiges Ventures has launched its second biopharma fund, which will invest in seed and early stage pharmaceuticals and medical devices worldwide. Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan) said it will invest up to $30 million in the fund, which is targeting $150 million. Taiho had also invested $30 million in Remiges' first fund, which the biopharma said gave it more access to early stage research (see "Remiges' Pipeline Remedy")...